Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potent toxin reveals new antibiotic resistance mechanism

12.09.2003


One of the great frustrations of modern medicine is the creeping ability of pathogenic microbes to develop resistance to the antibiotics we throw at them.



More and more, microbes are able to eliminate, modify and sequester the toxic molecules that make up the arsenal of antibiotics that humans use to treat infection, making once-miraculous drugs increasingly impotent. Now, adding to the mix of devices dangerous microbes deploy to evade destruction by antibiotics, scientists have discovered another way pathogens escape from the most potent drugs: self-sacrifice.

It is the equivalent of the courageous soldier throwing himself on a grenade, says Jon S. Thorson, a University of Wisconsin-Madison professor of pharmacy and the senior author of a paper describing the newfound method of antibiotic resistance published in this week’s (Sept. 12) edition of the journal Science.


"It is a new paradigm for resistance," says Thorson. "It points to the fact that bacteria continue to find new routes to evade these drugs."

The discovery was made by Thorson and colleagues John B. Biggins and Kenolisa C. Onwueme of the Sloan-Kettering Division, Joan and Sanford A. Weill Graduate School of Medical Sciences, Cornell University Cancer Center. Biggins is now at the UW-Madison School of Pharmacy.

The new finding was made using a highly potent anticancer agent known as an enediyne. Enediynes are a class of anti-tumor antibiotics that work by shredding DNA and disrupting the ability of a cell - such as cancer cell or a unicellular organism like a bacterium - to function and reproduce. They rank among the most potent naturally occurring antibiotics, and only a few molecules are required to destroy a cell.

In nature, soil bacteria use enediynes to create a buffer, a very localized environment free from competing microbes, which could overwhelm the slow-growing enediyne-producing bugs. But to survive in the toxic environment it creates, the microbe must have a way to survive its own poisons.

This is especially true, Thorson says, if one of the toxic molecules a bacterium secretes is soaked up by the bacterium itself. To protect itself, the bacterium quickly deploys a protein that intercepts the misdirected enediyne before it finds and destroys the organism’s DNA.

"Instead of cleaving DNA, the enediyne cleaves the protein and thereby inactivates itself," says Thorson. "By detonating its ’warhead’ to cleave the protein instead of the DNA, the cell is preserved. It’s somewhat inefficient, but at least the cell survives."

Over time, many antibiotic-producing microbes have evolved a variety of ways of not succumbing to the toxins they use to keep competitors at bay. But these methods of evading their own chemical warfare agents tend to be shared among bacteria, says Thorson, and are at the root of antibiotic resistance among the pathogenic bacteria that also borrow the defense mechanisms.

Scientists have long known that bacteria can thwart antibiotics by rearranging their chemistry to keep a drug from binding to a cell. What’s more, bacteria have learned how to clean house by quickly pumping antibiotic molecules out of affected cells. They also have acquired the trick of making molecular ’sponges,’ proteins that bind to antibiotics and take the drugs out of the game before they can do their lethal work.

The new mechanism found by Thorson’s group does not bode well for the fight against dangerous and sometimes deadly bacteria.

"Many of our drugs are coming from soil bacteria like these," Thorson says referring to the enediyne-producing bacteria with which he works. "This is the first known example of this kind of self-sacrifice mechanism for resistance. It points to the fact that bacteria continue to find new routes to evade these (antibiotic) molecules."

It would be surprising, Thorson argues, for this new mechanism to be unique to the enediyne-producing bacteria.

"One of the questions we’ve asked ourselves is, ’[Is] this a once-in-a-blue-moon discovery - or will this mechanism be found in other organisms?’ Since nature usually sticks with what works, I would not be surprised if we see this mechanism pop up again."


###
The work conducted by the Wisconsin team was funded in part by the National Institutes of Health.

- Terry Devitt (608) 262-8282, trdevitt@wisc.edu

Jon S. Thorson | EurekAlert!
Further information:
http://www.wisc.edu/

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>